SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-21-015744
Filing Date
2021-05-04
Accepted
2021-05-04 16:45:34
Documents
12
Period of Report
2021-05-04
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K brhc10023913_8k.htm   iXBRL 8-K 98628
  Complete submission text file 0001140361-21-015744.txt   246331

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA alxn-20210504.xsd EX-101.SCH 3920
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE alxn-20210504_lab.xml EX-101.LAB 22544
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alxn-20210504_pre.xml EX-101.PRE 16040
5 EXTRACTED XBRL INSTANCE DOCUMENT brhc10023913_8k_htm.xml XML 4070
Mailing Address 121 SEAPORT BOULEVARD BOSTON MA 02210
Business Address 121 SEAPORT BOULEVARD BOSTON MA 02210 4752302596
ALEXION PHARMACEUTICALS, INC. (Filer) CIK: 0000899866 (see all company filings)

IRS No.: 133648318 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-27756 | Film No.: 21889294
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences